Serum microRNAs as Tool to Predict Early Response to Benralizumab in Severe Eosinophilic Asthma

Severe eosinophilic asthma poses a serious health and economic problem, so new therapy approaches have been developed to control it, including biological drugs such as benralizumab, which is a monoclonal antibody that binds to IL-5 receptor alpha subunit and depletes peripheral blood eosinophils rap...

Descripción completa

Detalles Bibliográficos
Autores principales: Cañas, José A., Valverde-Monge, Marcela, Rodrigo-Muñoz, José M., Sastre, Beatriz, Gil-Martínez, Marta, García-Latorre, Raquel, Rial, Manuel J., Gómez-Cardeñosa, Aida, Fernández-Nieto, Mar, Pinillos-Robles, Erwin J., Rodríguez-Nieto, María J., González-Mangado, Nicolás, Sastre, Joaquín, del Pozo, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912443/
https://www.ncbi.nlm.nih.gov/pubmed/33525548
http://dx.doi.org/10.3390/jpm11020076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912443/
https://www.ncbi.nlm.nih.gov/pubmed/33525548
http://dx.doi.org/10.3390/jpm11020076

Ejemplares similares